Loading…

Emerging 3D printing technologies for drug delivery devices: Current status and future perspective

[Display omitted] The ‘one-size-fits-all’ approach followed by conventional drug delivery platforms often restricts its application in pharmaceutical industry, due to the incapability of adapting to individual pharmacokinetic traits. Driven by the development of additive manufacturing (AM) technolog...

Full description

Saved in:
Bibliographic Details
Published in:Advanced drug delivery reviews 2021-07, Vol.174, p.294-316
Main Authors: Wang, Jiawei, Zhang, Yu, Aghda, Niloofar Heshmati, Pillai, Amit Raviraj, Thakkar, Rishi, Nokhodchi, Ali, Maniruzzaman, Mohammed
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[Display omitted] The ‘one-size-fits-all’ approach followed by conventional drug delivery platforms often restricts its application in pharmaceutical industry, due to the incapability of adapting to individual pharmacokinetic traits. Driven by the development of additive manufacturing (AM) technology, three-dimensional (3D) printed drug delivery medical devices have gained increasing popularity, which offers key advantages over traditional drug delivery systems. The major benefits include the ability to fabricate 3D structures with customizable design and intricate architecture, and most importantly, ease of personalized medication. Furthermore, the emergence of multi-material printing and four-dimensional (4D) printing integrates the benefits of multiple functional materials, and thus provide widespread opportunities for the advancement of personalized drug delivery devices. Despite the remarkable progress made by AM techniques, concerns related to regulatory issues, scalability and cost-effectiveness remain major hurdles. Herein, we provide an overview on the latest accomplishments in 3D printed drug delivery devices as well as major challenges and future perspectives for AM enabled dosage forms and drug delivery systems.
ISSN:0169-409X
1872-8294
DOI:10.1016/j.addr.2021.04.019